PT-2024-31272 · Drug · Drug

Published 2024-09-06 · Updated 2024-09-12 · CVE-2024-44837

Positive Technologies (AI Summary)

CVSS v3.1

5.4

Medium

Base vector

AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Name of the Vulnerable Software and Affected Versions Drug version 1.0

Description A cross-site scripting (XSS) vulnerability in the component Manager.java of Drug allows attackers to execute arbitrary web scripts or HTML via a crafted payload injected into the user parameter. This issue can be exploited by injecting malicious data into the user parameter, leading to the execution of unauthorized scripts or HTML code.

Recommendations For Drug version 1.0, consider disabling the Manager.java component or restricting access to the user parameter until a patch is available. As a temporary workaround, avoid using the user parameter in the affected component to minimize the risk of exploitation.

Exploit

Fix

XSS

Weakness Enumeration

CWE-79

Related Identifiers

CVE-2024-44837

Affected Products

Drug

References · 7

• 🔥 https://kaput-raptorex-7c1.notion.site/drug-1-0-DOM-based-cross-site-scripting-fae620f769304f67a7488a961d048672 · Exploit
• https://nvd.nist.gov/vuln/detail/CVE-2024-44837 · Security Note
• https://osv.dev/vulnerability/CVE-2024-44837 · Vendor Advisory
• https://t.me/cvedetector/4971 · Telegram Post
• https://twitter.com/CVEnew/status/1832046407898812819 · Twitter Post
• https://t.me/cvenotify/94373 · Telegram Post
• https://twitter.com/VulmonFeeds/status/1832096973945520504 · Twitter Post